If you chose a regimen other than VRd, where do you practice?
-
-
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
For a young myeloma pt with R-ISS stage 3 , I might consider quadruple ( though I worry about cost and stem cell collection with Dara and Imid use in conjunction) . For others I use VRD
-
I save those expen$ive medicines for later - we made this mistake before with CHOP vs ProMACEMOPP or ProMACECYTABOM - sometimes less is more. If adding Dara doesn't improve cure rate is it worth it?
- Još 5 drugih odgovora
Novi razgovor -
-
-
Depends on fit/frail, genetic risk, and patient preference! Clinical trial participation always encouraged and preferred upfront.
- Kraj razgovora
Novi razgovor -
-
-
VRD for standard risk. KRD for high risk. Practice at IU
Kraj razgovora
Novi razgovor -
-
VDT as it has been recently approved in Turkey.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
most of the world dont have the access dara in first line
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
VRd for most standard risk, DVRd for selected fit high-risk patients on the basis of superior MRD negativity rates with quads when compared to triplets in RCTs.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.